StoneX Group’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.6K Buy
+12,092
New +$17.6K ﹤0.01% 1318
2026
Q1
Sell
-16,917
Closed -$23.3K 1212
2025
Q4
$23.3K Buy
+16,917
New +$35.4K ﹤0.01% 966

Other funds holding STIM

StoneX Group's STIM Position: Q2 2026 in Review

StoneX Group opened a new position in Neuronetics (STIM) in Q2 2026: 12,092 shares worth $18.6K. The stake represents ﹤0.01% of the portfolio and ranks #1318 among its holdings. This is a return to the name: StoneX Group previously reported a position in STIM as recently as Q4 2025.

StoneX Group first reported a position in STIM in Q4 2025 and has held it in 2 quarters since. The position peaked at $23.3K in Q4 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • StoneX Group held 12,092 shares of Neuronetics worth $18.6K as of Q2 2026.
  • Neuronetics was a new StoneX Group position in Q2 2026.
  • Neuronetics made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1318 holding.
  • StoneX Group first reported a position in Neuronetics in Q4 2025 and has held it in 2 quarters since.
  • StoneX Group's Neuronetics position peaked at $23.3K in Q4 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.